Borderline personality disorder Mental and Behavioural Disorders Emotionally unstable personality disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A full diagnosis of BPD: meeting Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for BPD measured by a SCID-P-5, a structured clinical interview (Arntz et al., 2017) 2. Aged above 18 years 3. The primary caregiver to at least one child under the age of 8 years at the start of the group; whereby the acute welfare of the child was not endangered 4. Dutch speaking; able to comprehend Dutch at a level sufficient to complete self-report instruments, the assignments, the group training and individual sessions 5. Willing and able to commit to attending a 2-hour group once a week for 12 weeks, all measurements and 45 minutes individual session every other week
Exclusion criteria
Exclusion criteria: 1. Lifetime psychosis or bipolar disorder type I 2. Insufficient cognitive capacity to comprehend the topics being discussed; screened by the SCIL (screener for intelligence and learning difficulties) with a cut-off score of 19 (Kaal et al. 2015) 3. Significant substance abuse that would have an impact on group functioning; as per clinical judgement following discussion with the research team 4. Start of new medication within 3 months before the start of this study Participants will not be excluded due to concurrent treatment (pharmacological or non-pharmacological)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Parenting behaviour measured using the Dutch version of the Alabama Parenting Questionnaire (APQ) at T=0 before baseline, T=1 start of treatment, T=2 mid-treatment, T=3 end of treatment and T=4 follow-up 2. Parental stress measured using the Dutch Parental Stress Index-child report (Nijmeegse Ouderlijke Stress Index Kinderen; NOSI-K) at T=0 before baseline, T=1 start of treatment, T=2 mid-treatment, T=3, end of treatment and T=4 follow-up 3. Idiosyncratic outcome measured using a short 15-item idiosyncratic assessment (IA) biweekly during the baseline and treatment phase (T=0 to T=3), biweekly during the baseline and treatment phase | — |
Secondary
| Measure | Time frame |
|---|---|
| Potential confounding factor: group atmosphere measured using the Group Session Rating Scale (GSRS) weekly at Weeks 1 -12 during treatment | — |
Countries
Netherlands